Gujarat Kidney And Super Speciality Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company has filed a statement with the stock exchange reporting deviation(s) or variation(s) under Regulation 32 of SEBI's Listing Obligations and Disclosure Requirements. This regulation requires companies to disclose any differences between the actual use of funds raised from the market (such as via IPO, rights issue, or preferential allotment) and the originally stated purpose disclosed at the time of fundraising. The filing indicates that the company's actual deployment of proceeds has not fully matched its earlier disclosed plan. Specific details on the amount and nature of the deviation are not available in the headline-level disclosure.
Deviation in the use of raised funds is generally viewed as a negative signal by investors, as it suggests the company has used money in ways different from what was originally promised. Shareholders should look at the full filing to understand the size and reason for the deviation, as recurring or unexplained variations can raise governance concerns and weigh on stock sentiment.